ALBKY

ALBKY is in a clear Stage 2 uptrend supported by rising EMAs and bullish pattern confirmation. However, price is extreme overbought and extended well above the 9- and 20-day EMAs, signaling short-term exhaustion. Immediate entry risks adverse pullbacks. The Value + EPS strategy favors waiting for a disciplined pullback into dynamic support (EMAs) to optimize risk-reward before re-engaging.

• ↑Profits climbed 44% YoY to €943 M in 2025, normalized ROTCE at 13.9%
• ↑Strong CET1 ratio of 15.7% supports a €519 M distribution plan
• ↓Negative earnings yield and weak profitability factor suggest overvaluation